HEADER HYDROLASE 01-MAR-23 8IL3 TITLE CRYO-EM STRUCTURE OF CD38 IN COMPLEX WITH FTL004 COMPND MOL_ID: 1; COMPND 2 MOLECULE: LIGHT CHAIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: HEAVY CHAIN; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: ADP-RIBOSYL CYCLASE/CYCLIC ADP-RIBOSE HYDROLASE 1; COMPND 11 CHAIN: C; COMPND 12 SYNONYM: 2'-PHOSPHO-ADP-RIBOSYL CYCLASE,2'-PHOSPHO-ADP-RIBOSYL COMPND 13 CYCLASE/2'-PHOSPHO-CYCLIC-ADP-RIBOSE TRANSFERASE,2'-PHOSPHO-CYCLIC- COMPND 14 ADP-RIBOSE TRANSFERASE,ADP-RIBOSYL CYCLASE 1,ADPRC 1,CYCLIC ADP- COMPND 15 RIBOSE HYDROLASE 1,CADPR HYDROLASE 1,T10; COMPND 16 EC: 3.2.2.6; COMPND 17 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_TAXID: 9606; SOURCE 4 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 6 EXPRESSION_SYSTEM_CELL_LINE: HEK293; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_TAXID: 9606; SOURCE 10 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 11 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 12 EXPRESSION_SYSTEM_CELL_LINE: HEK293; SOURCE 13 MOL_ID: 3; SOURCE 14 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 15 ORGANISM_COMMON: HUMAN; SOURCE 16 ORGANISM_TAXID: 9606; SOURCE 17 GENE: CD38; SOURCE 18 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 19 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 20 EXPRESSION_SYSTEM_CELL_LINE: HEK293 KEYWDS MONOCLONAL ANTIBODY, HYDROLASE EXPDTA ELECTRON MICROSCOPY AUTHOR J.YANG,Y.WANG,G.ZHANG REVDAT 2 06-NOV-24 8IL3 1 REMARK REVDAT 1 29-MAR-23 8IL3 0 JRNL AUTH G.ZHANG,C.GUO,Y.WANG,X.ZHANG,S.LIU,W.QU,C.CHEN,L.YAN,Z.YANG, JRNL AUTH 2 Z.ZHANG,X.JIANG,X.CHEN,H.LIU,Q.LAI,X.WEI,Y.LU,S.ZHAO,H.DENG, JRNL AUTH 3 Y.WANG,L.YU,H.YU,Y.WU,Z.SU,P.CHEN,Z.REN,M.YU,F.QU,Y.LUO, JRNL AUTH 4 L.GOU,Q.LI,Y.HUANG,F.MA,J.YANG JRNL TITL FTL004, AN ANTI-CD38 MAB WITH NEGLIGIBLE RBC BINDING AND JRNL TITL 2 ENHANCED PRO-APOPTOTIC ACTIVITY, IS A NOVEL CANDIDATE FOR JRNL TITL 3 TREATMENTS OF MULTIPLE MYELOMA AND NON-HODGKIN LYMPHOMA. JRNL REF J HEMATOL ONCOL V. 15 177 2022 JRNL REFN ISSN 1756-8722 JRNL PMID 36581954 JRNL DOI 10.1186/S13045-022-01395-0 REMARK 2 REMARK 2 RESOLUTION. 3.86 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.860 REMARK 3 NUMBER OF PARTICLES : 34435 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8IL3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 06-MAR-23. REMARK 100 THE DEPOSITION ID IS D_1300035400. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : CRYO-EM STRUCTURE OF CD38 IN REMARK 245 COMPLEX WITH FTL004 REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.20 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K2 QUANTUM (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 752.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2826.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 51 -152.13 -118.33 REMARK 500 SER A 56 -38.19 -133.35 REMARK 500 SER A 71 -158.17 -151.13 REMARK 500 THR A 73 -35.73 -132.90 REMARK 500 SER A 95 32.29 -146.13 REMARK 500 TYR A 144 75.19 -108.82 REMARK 500 GLU A 147 -74.31 -106.84 REMARK 500 THR A 184 79.37 -104.90 REMARK 500 CYS B 22 -165.14 -103.36 REMARK 500 ILE B 48 -61.26 -102.22 REMARK 500 HIS B 59 115.27 -160.85 REMARK 500 THR B 140 64.34 -102.87 REMARK 500 ASP B 149 69.40 63.25 REMARK 500 TRP B 159 -117.70 48.53 REMARK 500 THR B 165 -38.09 -131.56 REMARK 500 VAL B 168 109.35 -56.68 REMARK 500 THR B 196 -79.75 -76.44 REMARK 500 TYR B 199 78.02 -101.96 REMARK 500 THR C 93 52.23 -117.45 REMARK 500 VAL C 94 111.99 -37.51 REMARK 500 ASN C 97 -57.78 73.92 REMARK 500 ARG C 104 -98.77 62.68 REMARK 500 CYS C 137 -95.71 -137.07 REMARK 500 ASP C 156 -79.42 -105.81 REMARK 500 SER C 158 55.63 -90.21 REMARK 500 ASP C 179 -102.29 65.00 REMARK 500 ASN C 206 63.86 -102.49 REMARK 500 GLN C 208 80.19 55.18 REMARK 500 CYS C 231 -7.22 75.84 REMARK 500 ASN C 247 67.68 60.74 REMARK 500 CYS C 252 81.93 -152.69 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-35526 RELATED DB: EMDB REMARK 900 CRYO-EM STRUCTURE OF CD38 IN COMPLEX WITH FTL004 DBREF 8IL3 A 1 218 PDB 8IL3 8IL3 1 218 DBREF 8IL3 B 1 215 PDB 8IL3 8IL3 1 215 DBREF 8IL3 C 25 256 UNP P28907 CD38_HUMAN 48 279 SEQRES 1 A 218 ASP ILE VAL LEU THR GLN SER PRO ALA SER LEU ALA VAL SEQRES 2 A 218 SER PRO GLY GLN ARG ALA THR ILE THR CYS ARG ALA SER SEQRES 3 A 218 GLU SER VAL ASP ASN PHE GLY ILE THR PHE MET HIS TRP SEQRES 4 A 218 TYR GLN GLN LYS PRO GLY GLN PRO PRO LYS LEU LEU ILE SEQRES 5 A 218 TYR ARG ALA SER ASN LEU GLU SER GLY VAL PRO ALA ARG SEQRES 6 A 218 PHE SER GLY SER GLY SER ARG THR ASP PHE THR LEU THR SEQRES 7 A 218 ILE ASN PRO VAL GLU ALA ASN ASP THR ALA ASN TYR TYR SEQRES 8 A 218 CYS GLN GLN SER SER LYS ASP PRO ARG THR PHE GLY GLN SEQRES 9 A 218 GLY THR LYS LEU GLU ILE LYS ARG THR VAL ALA ALA PRO SEQRES 10 A 218 SER VAL PHE ILE PHE PRO PRO SER ASP GLU GLN LEU LYS SEQRES 11 A 218 SER GLY THR ALA SER VAL VAL CYS LEU LEU ASN ASN PHE SEQRES 12 A 218 TYR PRO ARG GLU ALA LYS VAL GLN TRP LYS VAL ASP ASN SEQRES 13 A 218 ALA LEU GLN SER GLY ASN SER GLN GLU SER VAL THR GLU SEQRES 14 A 218 GLN ASP SER LYS ASP SER THR TYR SER LEU SER SER THR SEQRES 15 A 218 LEU THR LEU SER LYS ALA ASP TYR GLU LYS HIS LYS VAL SEQRES 16 A 218 TYR ALA CYS GLU VAL THR HIS GLN GLY LEU SER SER PRO SEQRES 17 A 218 VAL THR LYS SER PHE ASN ARG GLY GLU CYS SEQRES 1 B 215 GLN VAL GLN LEU VAL GLN SER GLY SER GLU LEU LYS LYS SEQRES 2 B 215 PRO GLY ALA SER VAL LYS VAL SER CYS LYS ALA SER GLY SEQRES 3 B 215 TYR THR PHE THR ASP TYR ASN VAL HIS TRP ILE ARG GLN SEQRES 4 B 215 ALA PRO GLY GLN GLY LEU GLU TRP ILE GLY TYR PHE TYR SEQRES 5 B 215 PRO ARG ASN GLY ALA THR HIS TYR ASN GLN LYS PHE THR SEQRES 6 B 215 GLY ARG ALA VAL LEU SER ALA ASP THR SER VAL SER THR SEQRES 7 B 215 ALA TYR LEU GLN ILE SER SER LEU LYS ALA GLU ASP THR SEQRES 8 B 215 ALA VAL TYR PHE CYS ALA ARG GLY GLU THR PRO GLY THR SEQRES 9 B 215 PHE PRO TYR TRP GLY GLN GLY THR LEU VAL THR VAL SER SEQRES 10 B 215 SER ALA SER THR LYS GLY PRO SER VAL PHE PRO LEU ALA SEQRES 11 B 215 PRO SER SER LYS SER THR SER GLY GLY THR ALA ALA LEU SEQRES 12 B 215 GLY CYS LEU VAL LYS ASP TYR PHE PRO GLU PRO VAL THR SEQRES 13 B 215 VAL SER TRP ASN SER GLY ALA LEU THR SER GLY VAL HIS SEQRES 14 B 215 THR PHE PRO ALA VAL LEU GLN SER SER GLY LEU TYR SER SEQRES 15 B 215 LEU SER SER VAL VAL THR VAL PRO SER SER SER LEU GLY SEQRES 16 B 215 THR GLN THR TYR ILE CYS ASN VAL ASN HIS LYS PRO SER SEQRES 17 B 215 ASN THR LYS VAL ASP LYS LYS SEQRES 1 C 232 GLN GLN TRP SER GLY PRO GLY THR THR LYS ARG PHE PRO SEQRES 2 C 232 GLU THR VAL LEU ALA ARG CYS VAL LYS TYR THR GLU ILE SEQRES 3 C 232 HIS PRO GLU MET ARG HIS VAL ASP CYS GLN SER VAL TRP SEQRES 4 C 232 ASP ALA PHE LYS GLY ALA PHE ILE SER LYS HIS PRO CYS SEQRES 5 C 232 ASN ILE THR GLU GLU ASP TYR GLN PRO LEU MET LYS LEU SEQRES 6 C 232 GLY THR GLN THR VAL PRO CYS ASN LYS ILE LEU LEU TRP SEQRES 7 C 232 SER ARG ILE LYS ASP LEU ALA HIS GLN PHE THR GLN VAL SEQRES 8 C 232 GLN ARG ASP MET PHE THR LEU GLU ASP THR LEU LEU GLY SEQRES 9 C 232 TYR LEU ALA ASP ASP LEU THR TRP CYS GLY GLU PHE ASN SEQRES 10 C 232 THR SER LYS ILE ASN TYR GLN SER CYS PRO ASP TRP ARG SEQRES 11 C 232 LYS ASP CYS SER ASN ASN PRO VAL SER VAL PHE TRP LYS SEQRES 12 C 232 THR VAL SER ARG ARG PHE ALA GLU ALA ALA CYS ASP VAL SEQRES 13 C 232 VAL HIS VAL MET LEU ASN GLY SER ARG SER LYS ILE PHE SEQRES 14 C 232 ASP LYS ASN SER THR PHE GLY SER VAL GLU VAL HIS ASN SEQRES 15 C 232 LEU GLN PRO GLU LYS VAL GLN THR LEU GLU ALA TRP VAL SEQRES 16 C 232 ILE HIS GLY GLY ARG GLU ASP SER ARG ASP LEU CYS GLN SEQRES 17 C 232 ASP PRO THR ILE LYS GLU LEU GLU SER ILE ILE SER LYS SEQRES 18 C 232 ARG ASN ILE GLN PHE SER CYS LYS ASN ILE TYR HELIX 1 AA1 SER A 125 SER A 131 1 7 HELIX 2 AA2 SER A 186 GLU A 191 1 6 HELIX 3 AA3 LYS B 87 THR B 91 5 5 HELIX 4 AA4 PRO B 190 GLN B 197 1 8 HELIX 5 AA5 ARG C 35 HIS C 51 1 17 HELIX 6 AA6 ASP C 58 ILE C 71 1 14 HELIX 7 AA7 HIS C 74 ILE C 78 5 5 HELIX 8 AA8 TYR C 83 LEU C 89 1 7 HELIX 9 AA9 LYS C 106 GLN C 116 1 11 HELIX 10 AB1 THR C 125 ALA C 131 1 7 HELIX 11 AB2 ASN C 160 ALA C 176 1 17 HELIX 12 AB3 THR C 198 GLU C 203 1 6 HELIX 13 AB4 ASP C 233 SER C 241 1 9 SHEET 1 AA1 2 SER A 10 VAL A 13 0 SHEET 2 AA1 2 LYS A 107 ILE A 110 1 O GLU A 109 N LEU A 11 SHEET 1 AA2 3 ALA A 19 THR A 20 0 SHEET 2 AA2 3 ASP A 74 ILE A 79 -1 O ILE A 79 N ALA A 19 SHEET 3 AA2 3 CYS A 23 ARG A 24 -1 N CYS A 23 O PHE A 75 SHEET 1 AA3 3 ALA A 19 THR A 20 0 SHEET 2 AA3 3 ASP A 74 ILE A 79 -1 O ILE A 79 N ALA A 19 SHEET 3 AA3 3 PHE A 66 SER A 69 -1 N SER A 67 O THR A 78 SHEET 1 AA4 2 ASP A 30 ASN A 31 0 SHEET 2 AA4 2 ILE A 34 THR A 35 -1 O ILE A 34 N ASN A 31 SHEET 1 AA5 3 LYS A 49 LEU A 50 0 SHEET 2 AA5 3 TYR A 40 GLN A 42 -1 N GLN A 41 O LYS A 49 SHEET 3 AA5 3 ASN A 89 TYR A 91 -1 O ASN A 89 N GLN A 42 SHEET 1 AA6 2 ALA A 134 SER A 135 0 SHEET 2 AA6 2 THR A 184 LEU A 185 -1 O LEU A 185 N ALA A 134 SHEET 1 AA7 3 TRP A 152 VAL A 154 0 SHEET 2 AA7 3 TYR A 196 GLU A 199 -1 O ALA A 197 N LYS A 153 SHEET 3 AA7 3 THR A 210 LYS A 211 -1 O LYS A 211 N CYS A 198 SHEET 1 AA8 2 SER A 166 VAL A 167 0 SHEET 2 AA8 2 LEU A 179 SER A 180 -1 O SER A 180 N SER A 166 SHEET 1 AA9 2 GLN B 3 LEU B 4 0 SHEET 2 AA9 2 ALA B 24 SER B 25 -1 O SER B 25 N GLN B 3 SHEET 1 AB1 5 GLU B 10 LYS B 12 0 SHEET 2 AB1 5 THR B 112 VAL B 116 1 O THR B 115 N LYS B 12 SHEET 3 AB1 5 ALA B 92 ARG B 98 -1 N ALA B 92 O VAL B 114 SHEET 4 AB1 5 HIS B 35 GLN B 39 -1 N GLN B 39 O VAL B 93 SHEET 5 AB1 5 LEU B 45 TRP B 47 -1 O GLU B 46 N ARG B 38 SHEET 1 AB2 4 GLU B 10 LYS B 12 0 SHEET 2 AB2 4 THR B 112 VAL B 116 1 O THR B 115 N LYS B 12 SHEET 3 AB2 4 ALA B 92 ARG B 98 -1 N ALA B 92 O VAL B 114 SHEET 4 AB2 4 TYR B 107 TRP B 108 -1 O TYR B 107 N ARG B 98 SHEET 1 AB3 3 VAL B 20 SER B 21 0 SHEET 2 AB3 3 THR B 78 LEU B 81 -1 O LEU B 81 N VAL B 20 SHEET 3 AB3 3 ALA B 72 ASP B 73 -1 N ASP B 73 O THR B 78 SHEET 1 AB4 2 GLY B 49 TYR B 50 0 SHEET 2 AB4 2 HIS B 59 TYR B 60 -1 O HIS B 59 N TYR B 50 SHEET 1 AB5 4 PRO B 128 LEU B 129 0 SHEET 2 AB5 4 ALA B 141 TYR B 150 -1 O GLY B 144 N LEU B 129 SHEET 3 AB5 4 TYR B 181 VAL B 189 -1 O VAL B 187 N LEU B 143 SHEET 4 AB5 4 VAL B 168 HIS B 169 -1 N HIS B 169 O VAL B 186 SHEET 1 AB6 4 PRO B 128 LEU B 129 0 SHEET 2 AB6 4 ALA B 141 TYR B 150 -1 O GLY B 144 N LEU B 129 SHEET 3 AB6 4 TYR B 181 VAL B 189 -1 O VAL B 187 N LEU B 143 SHEET 4 AB6 4 VAL B 174 LEU B 175 -1 N VAL B 174 O SER B 182 SHEET 1 AB7 2 CYS B 201 ASN B 202 0 SHEET 2 AB7 2 ASP B 213 LYS B 214 -1 O LYS B 214 N CYS B 201 SHEET 1 AB8 2 ASP C 179 VAL C 181 0 SHEET 2 AB8 2 VAL C 212 LEU C 215 1 O GLN C 213 N ASP C 179 SHEET 1 AB9 3 MET C 184 LEU C 185 0 SHEET 2 AB9 3 TRP C 218 ILE C 220 1 O TRP C 218 N LEU C 185 SHEET 3 AB9 3 ASN C 254 ILE C 255 1 O ILE C 255 N VAL C 219 SSBOND 1 CYS C 44 CYS C 59 1555 1555 2.97 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000